TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in TremblerJ mice

Experimental Neurology - Tập 224 - Trang 495-506 - 2010
Zarife Sahenk1, Gloria Galloway2, Chris Edwards1, Vinod Malik1, Brian K. Kaspar1, Amy Eagle1, Brent Yetter1, Alison Forgie3, David Tsao3, John C. Lin3
1Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA
2Division of Neurology, Department of Pediatrics at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA
3Rinat, Pfizer Inc., South San Francisco, CA, USA

Tài liệu tham khảo

Beuche, 1985, A quantitative assessment of myelin sheaths in the peripheral nerves of dystrophic, quaking, and trembler mutants, Acta Neuropathol., 66, 29, 10.1007/BF00698292 Bothwell, 1995, Functional interactions of neurotrophins and neurotrophin receptors, Annu. Rev. Neurosci., 18, 223, 10.1146/annurev.ne.18.030195.001255 Chan, 2001, Neurotrophins are key mediators of the myelination program in the peripheral nervous system, Proc. Natl. Acad. Sci. U. S. A., 98, 14661, 10.1073/pnas.251543398 Davies, 1993, p75-Deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins, Neuron, 11, 565, 10.1016/0896-6273(93)90069-4 de Waegh, 1990, Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell–axon interactions, J. Neurosci., 10, 1855, 10.1523/JNEUROSCI.10-06-01855.1990 de Waegh, 1991, Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts, J. Neurosci. Res., 30, 201, 10.1002/jnr.490300121 de Waegh, 1992, Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells, Cell, 68, 451, 10.1016/0092-8674(92)90183-D Friede, 1985, Combined scatter diagrams of sheath thickness and fibre calibre in human sural nerves: changes with age and neuropathy, J. Neurol. Neurosurg. Psychiatry, 48, 749, 10.1136/jnnp.48.8.749 Gao, 1995, Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy, Ann. Neurol., 38, 30, 10.1002/ana.410380108 Goldstein, 1988, mRNA levels of all three neurofilament proteins decline following nerve transection, Brain Res., 427, 287, 10.1016/0169-328X(88)90051-4 Haidet, 2008, Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors, Proc. Natl. Acad. Sci. U. S. A., 105, 4318, 10.1073/pnas.0709144105 Hall, 1986, Regeneration in cellular and acellular autografts in the peripheral nervous system, Neuropathol. Appl. Neurobiol., 12, 27, 10.1111/j.1365-2990.1986.tb00679.x Hall, 1989, Regeneration in the peripheral nervous system, Neuropathol. Appl. Neurobiol., 15, 513, 10.1111/j.1365-2990.1989.tb01251.x Hoffman, 1988, Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific beta-tubulin isotype, Proc. Natl. Acad. Sci. U. S. A., 85, 4530, 10.1073/pnas.85.12.4530 Hoffman, 1987, Neurofilament gene expression: a major determinant of axonal caliber, Proc. Natl. Acad. Sci. U. S. A., 84, 3472, 10.1073/pnas.84.10.3472 Jung, 2000, Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ, Cell Motil. Cytoskeleton, 47, 120, 10.1002/1097-0169(200010)47:2<120::AID-CM3>3.0.CO;2-6 Kaya, 2007, Ascorbic acid inhibits PMP22 expression by reducing cAMP levels, Neuromuscul. Disord., 17, 248, 10.1016/j.nmd.2006.12.008 Khajavi, 2007, Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy, Am. J. Hum. Genet., 81, 438, 10.1086/519926 Kirkpatrick, 1994, Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells, J. Neurosci., 14, 7440, 10.1523/JNEUROSCI.14-12-07440.1994 Lin, 2008, Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates, PLoS One, 3, e1900, 10.1371/journal.pone.0001900 McQuarrie, 1978, The effect of a conditioning lesion on the regeneration of motor axons, Brain Res., 152, 597, 10.1016/0006-8993(78)91116-2 Meekins, 2004, Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot–Marie–Tooth disease type 1A?, J. Peripher. Nerv. Syst., 9, 177, 10.1111/j.1085-9489.2004.09310.x Meekins, 2007, Axonal degeneration in the Trembler-j mouse demonstrated by stimulated single-fiber electromyography, Muscle Nerve, 36, 81, 10.1002/mus.20786 Meier, 1999, Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB, J. Neurosci., 19, 3847, 10.1523/JNEUROSCI.19-10-03847.1999 Mendler, 2008, Regeneration of reinnervated rat soleus muscle is accompanied by fiber transition toward a faster phenotype, J. Histochem. Cytochem., 56, 111, 10.1369/jhc.7A7322.2007 Mirsky, 2002, Schwann cells as regulators of nerve development, J. Physiol. Paris, 96, 17, 10.1016/S0928-4257(01)00076-6 Nelis, 1996, Estimation of the mutation frequencies in Charcot–Marie–Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study, Eur. J. Hum. Genet., 4, 25, 10.1159/000472166 Nelis, 2007 Oblinger, 1988, Axotomy-induced alterations in the synthesis and transport of neurofilaments and microtubules in dorsal root ganglion cells, J. Neurosci., 8, 1747, 10.1523/JNEUROSCI.08-05-01747.1988 Poduslo, 1996, Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF, Brain Res., 36, 280, 10.1016/0169-328X(95)00250-V Richardson, 1987, Axonal regeneration in dorsal spinal roots is accelerated by peripheral axonal transection, Brain Res., 411, 406, 10.1016/0006-8993(87)91096-1 Ruiz, 2005, Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice, Hum. Mol. Genet., 14, 1825, 10.1093/hmg/ddi189 Sadick, 1997, Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay, Exp. Cell Res., 234, 354, 10.1006/excr.1997.3614 Sahenk, 1999, Abnormal Schwann cell–axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination, Ann. N. Y. Acad. Sci., 883, 415, 10.1111/j.1749-6632.1999.tb08602.x Sahenk, 1992, Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule-associated proteins, J. Neurosci. Res., 32, 481, 10.1002/jnr.490320404 Sahenk, 2003, Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts, J. Peripher. Nerv. Syst., 8, 116, 10.1046/j.1529-8027.2003.03017.x Sahenk, 2005, NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients, Neurology, 65, 681, 10.1212/01.WNL.0000171978.70849.c5 Sahenk, 2008, Neurotrophin-3 deficient Schwann cells impair nerve regeneration, Exp. Neurol., 212, 552, 10.1016/j.expneurol.2008.04.015 Sayers, 2003, Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats, Diabetes, 52, 2372, 10.2337/diabetes.52.9.2372 Schweigreiter, 2006, The dual nature of neurotrophins, Bioessays, 28, 583, 10.1002/bies.20419 Sereda, 2003, Therapeutic administration of progesterone antagonist in a model of Charcot–Marie–Tooth disease (CMT-1A), Nat. Med., 9, 1533, 10.1038/nm957 Skre, 1974, Genetic and clinical aspects of Charcot–Marie–Tooth's disease, Clin. Genet., 6, 98, 10.1111/j.1399-0004.1974.tb00638.x Smith, 1997, A transcription-dependent switch controls competence of adult neurons for distinct modes of axon growth, J. Neurosci., 17, 646, 10.1523/JNEUROSCI.17-02-00646.1997 Starr, 1996, Neurofilament phosphorylation is modulated by myelination, J. Neurosci. Res., 44, 328, 10.1002/(SICI)1097-4547(19960515)44:4<328::AID-JNR3>3.0.CO;2-E Terenghi, 1999, Peripheral nerve regeneration and neurotrophic factors, J. Anat., 194, 1, 10.1046/j.1469-7580.1999.19410001.x Tetzlaff, 1988, Changes in cytoskeletal proteins in the rat facial nucleus following axotomy, J. Neurosci., 8, 3181, 10.1523/JNEUROSCI.08-09-03181.1988 Tetzlaff, 1996, Reductions in motoneuronal neurofilament synthesis by successive axotomies: a possible explanation for the conditioning lesion effect on axon regeneration, Exp. Neurol., 139, 95, 10.1006/exnr.1996.0084 Tokuoka, 2000, Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons, J. Cell Sci., 113, 1059, 10.1242/jcs.113.6.1059 Tsao, 2008, TrkB agonists ameliorate obesity and associated metabolic conditions in mice, Endocrinology, 149, 1038, 10.1210/en.2007-1166 Wang, 2008, Electrophysiologic findings and grip strength after nerve injuries in the rat forelimb, Muscle Nerve, 38, 1254, 10.1002/mus.20971 Wong, 1987, Changes in neurofilament gene expression occur after axotomy of dorsal root ganglion neurons: an in situ hybridization study, Metab. Brain Dis., 2, 291, 10.1007/BF00999699 Woolley, 2008, Developmental loss of NT-3 in vivo results in reduced levels of myelin-specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells, Glia, 56, 306, 10.1002/glia.20614 Yabe, 2000, Phospho-dependent association of neurofilament proteins with kinesin in situ, Cell Motil. Cytoskeleton, 45, 249, 10.1002/(SICI)1097-0169(200004)45:4<249::AID-CM1>3.0.CO;2-M Yuan, 2006, Deleting the phosphorylated tail domain of the neurofilament heavy subunit does not alter neurofilament transport rate in vivo, Neurosci. Lett., 393, 264, 10.1016/j.neulet.2005.10.029